
Human colon cancer cells are seen in this microscope image in 2015, with the nuclei stained red.
6:15 JST, April 27, 2022
Scientists have analyzed the full genetic blueprints of more than 18,000 cancer samples, finding new patterns of mutations that could help doctors provide better, more personalized treatment.
Their study, published April 21 in the journal Science, isn’t the first to do such comprehensive “whole genome” analyses of cancer samples. But no one has ever done so many.
“This is the largest cohort in the world. It is extraordinary,” said Serena Nik-Zainal of the University of Cambridge, who was part of the team.
Just over 12,200 surgical specimens came from patients recruited from the U.K. National Health Service as part of a project to study whole genomes from people with common cancers and rare diseases. The rest came from existing cancer data sets.
Researchers were able to analyze such a large number because of the same improvements in genetic sequencing technology that recently allowed scientists to finally finish decoding the entire human genome — more capable, accurate machines.
“We can really begin to tease out the underpinnings of the erosive sort of forces that go to sort of generate cancer,” said Andrew Futreal, a genomic medicine expert at MD Anderson Cancer Center in Houston who was not involved in the study.
Cancer is a disease of the genome, or full set of instructions for running cells, that occurs when changes in a person’s DNA cause cells to grow and divide uncontrollably. In 2020, there were about 19 million new cancer cases worldwide.
For the study, researchers looked at 19 different types — breast, colorectal, prostate, brain and others — and identified 58 new clues to the causes of cancer called “mutational signatures” that contribute to the development of the disease. They also confirmed 51 of more than 70 previously reported mutation patterns, Nik-Zainal said.
Some arise because of problems within a person’s cells; others are sparked by environmental exposures such as ultraviolet radiation, tobacco smoke or chemicals.
Knowing more of them “helps us to understand each person’s cancer more precisely,” which can help guide treatment, Nik-Zainal said.
Genetic sequencing is already being woven into cancer care as part of the growing trend of personalized medicine, or care based on a patient’s genes and specific disease. Now doctors will have much more information to draw from when they look at individual cancers.
To help doctors use this information, researchers developed a computer algorithm that will allow them to find common mutation patterns and seek out rare ones. Based on a particular pattern, Nik-Zainal said a doctor may suggest a certain course of action, such as getting immunotherapy.
Futreal said the data can also show doctors what tends to happen over time when a patient develops a cancer with a certain mutation pattern — helping them intervene earlier and hopefully stop the developing disease in its tracks.
"News Services" POPULAR ARTICLE
-
India Says It Attacked Pakistan, Pakistani Kashmir
-
Japan’s Nikkei Stock Average Ends Higher; NTT Data Surges on Takeover Report (UPDATE 1)
-
Putin Declares 3-Day May Ceasefire to Mark 80 Years Since World War Two Victory
-
Prime Minister Ishiba Reiterates Demand for U.S. Removal of Auto Tariffs
-
Panasonic to Cut 10,000 Employees, Expects to Book $900 Million Reform Costs
JN ACCESS RANKING
-
U.S. Holds Fire Over Yen Exchange Rate Targets; Bessent Said to Understand Negative Impact on Markets
-
Rents Mark 30-Year-High Rate of Rise; Decrease in Disposable Income May Dampen Personal Consumption
-
Japanese Govt Mulls Raising Number of Cars to be Imported Under Simplified Screen System in U.S. Tariff Negotiations
-
Japan Must Boost Its ‘Indispensability,’ Urges JETRO Chair; Convince United States That Cooperation Will Be Beneficial
-
Japan Presses U.S. to Scrap 25% Auto Tariffs as Ishiba Refuses Partial Trade Deal; No Deal Without ‘Total Rollback’